July 2021 - We are a multinational Contract Research Organization (CRO) focused on Cannabinoids, Psychedelics and Entheogens. Having worked with some of the top Sponsors in the space, we are confident that we will be a key player in unlocking the medicinal benefits of many new Therapeutics. 2012-July 2021 - Artcan/Apothca - Cannabis industry veteran - 2012. Launched a Vertically Integrated Cannabis business in MA. Raised over $20 million in capital, Ground-up Greenhouse and Outdoor cultivation, extraction labs, retail, wholesale, application drafting, team building, local and state lobbying, international experience, specifically Colombia, Israel and Peru.Licenses secured and operated and sold around the world. From South America to Israel. Multiple successful exits prior to Cannabis, (10+ years) in Pathology space. Sold PathOptions to EndoChoice, who then sold to Boston Scientific (BSX:NYSE).